Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mersana Therapeutics, Inc. (MRSN)  
$2.88 0.33 (10.28%) as of 4:30 Wed 4/24


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 120,580,000
Market Cap: 347.27(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.06 - $9.55
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. Co.'s platforms including Dolaflexin and Dolasynthen, deliver its auristatin DolaLock payload, as well as Immunosynthen, which delivers its stimulator of interferon genes (STING) agonist ImmunoLock payload. Co.'s product candidates include: upifitamab rilsodotin (UpRi), which is a Dolaflexin ADC targeting NaPi2b, an antigen expressed in ovarian cancer and other cancers; and XMT-1592, which is a Dolasynthen ADC targeting NaPi2b-expressing tumor cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 926,273
Total Buy Value $0 $0 $0 $3,050,230
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 11
Total Shares Sold 0 67,241 73,093 120,181
Total Sell Value $0 $179,202 $196,795 $466,241
Total People Sold 0 7 7 8
Total Sell Transactions 0 8 10 20
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 245
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2024-01-16 4 AS $2.71 $13,618 D/D (5,025) 23,328 20%     
   Bala Mohan SVP, Chief Development Officer   •       –      –    2024-01-16 4 AS $2.71 $9,298 D/D (3,431) 14,052 20%     
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2024-01-16 4 AS $2.71 $11,873 D/D (4,381) 27,403 20%     
   Misra Tushar SVP, Chief Manuf. Officer   •       –      –    2024-01-16 4 AS $2.71 $9,097 D/D (3,357) 17,966 20%     
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2024-01-16 4 AS $2.71 $28,208 D/D (10,409) 199,329 20%     
   Deschuytner Brian SVP, COO & CFO   •       –      –    2024-01-16 4 AS $2.71 $25,276 D/D (9,327) 54,511 20%     
   Protopapas Anna Director   –       •      –    2024-01-16 4 AS $2.71 $79,671 D/D (29,399) 125,153 20%     
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2024-01-15 4 OE $0.00 $0 D/D 5,352 28,353     -
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2024-01-15 4 OE $0.00 $0 D/D 15,208 209,738     -
   Deschuytner Brian SVP, COO & CFO   •       –      –    2024-01-15 4 OE $0.00 $0 D/D 10,208 63,838     -
   Protopapas Anna Director   –       •      –    2024-01-15 4 OE $0.00 $0 D/D 38,958 154,552     -
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2024-01-14 4 OE $0.00 $0 D/D 4,783 23,001     -
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2024-01-14 4 OE $0.00 $0 D/D 2,500 31,784     -
   Misra Tushar SVP, Chief Manuf. Officer   •       –      –    2024-01-14 4 OE $0.00 $0 D/D 1,458 21,323     -
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2024-01-14 4 OE $0.00 $0 D/D 4,792 194,530     -
   Deschuytner Brian SVP, COO & CFO   •       –      –    2024-01-14 4 OE $0.00 $0 D/D 6,250 55,630     -
   Protopapas Anna Director   –       •      –    2024-01-14 4 OE $0.00 $0 D/D 16,750 115,594     -
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 2,645 18,218     -
   Bala Mohan SVP, Chief Development Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 8,750 17,483     -
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 8,958 29,284     -
   Misra Tushar SVP, Chief Manuf. Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 7,083 19,865     -
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 9,375 189,738     -
   Deschuytner Brian SVP, COO & CFO   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 10,000 47,380     -
   Protopapas Anna Director   –       •      –    2024-01-13 4 OE $0.00 $0 D/D 31,250 98,844     -
   Mott David M Director   –       •      –    2024-01-02 4 A $0.00 $0 D/D 8,810 588,694     -
  245 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us